5-((E)-2-bromovinyl)-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione-13C4 15N2; 5-((E)-2-bromovinyl)-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione-13C4 15N2; (E)-5-(2-Bromovinyl)-2'-deoxyuridine-13C4 15N2; (E)-5-(2-Bromovinyl)deoxyuridine-13C4 15N2; (E)-5-O-(2-bromoethenyl)-2'-deoxyuridine-13C4 15N2; 5-[(1E)-2-Bromoethenyl]-2'-deoxyuridine-13C4 15N2;5-[(E)-2-Bromoethenyl]-2'-deoxyuridine-13C4 15N2; BVDU-13C4 15N2; Brivudin-13C4 15N2; Brivudine-13C4 15N2; Bromovinyldeoxyuridine-13C4 15N2; Helpin
Brivudine-13C4-15N2 is a fully characterized chemical compound used as a reference standard of API Brivudine. The standard offered is compliant with regulatory guidelines. Brivudine-13C4-15N2 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS -
